Since mutated KIT receptor is known to drive GIST sarcomas, it seemed possible that the moderate amplification of KITLG and resulting overexpression of the c-KIT ligand could be a driver, providing an autocrine loop. The gene discussed is KITLG; the disease is gastrointestinal stromal tumor.